The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/16500
StudyName: Eligibility Breast Neoplasms NCT02254031
Date of export from the portal: 02.07.2020
Date of Upload / last change: 19.07.2016
License: Creative Commons BY 4.0

----

Description: 
Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02254031
